thyroid us
TRANSCRIPT
![Page 1: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/1.jpg)
![Page 2: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/2.jpg)
![Page 3: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/3.jpg)
![Page 4: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/4.jpg)
Anatomy of thyroid glandAnatomy of thyroid gland
![Page 5: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/5.jpg)
![Page 6: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/6.jpg)
What are the indications for What are the indications for thyroid ultrasound?thyroid ultrasound?
Diffuse enlargement on physical Diffuse enlargement on physical examinationexamination
A palpable massA palpable mass A non palpable mass seen on other A non palpable mass seen on other
imaging( CT-MRI- nuclear scan)imaging( CT-MRI- nuclear scan) Abnormal thyroid function testsAbnormal thyroid function tests
![Page 7: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/7.jpg)
Thyroid diseasesThyroid diseases
Diffuse Diffuse Grave's diseaseGrave's disease Hashimoto Hashimoto
thyroiditisthyroiditis De Quervain's De Quervain's
thyroiditisthyroiditis
Focal Focal SolitarySolitary multinodularmultinodular
![Page 8: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/8.jpg)
Solitary thyroid noduleSolitary thyroid nodule
BenignBenign malignantmalignant
![Page 9: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/9.jpg)
General features of the General features of the solitary nodulesolitary nodule
Solid / cysticSolid / cystic Comet tail signComet tail sign MarginsMargins CalcificationCalcification Color flow imagingColor flow imaging
![Page 10: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/10.jpg)
Solid/CysticSolid/Cystic Nodules with large Nodules with large
cystic components are cystic components are usually benign nodules usually benign nodules that have undergone that have undergone cystic degeneration or cystic degeneration or hemorrhage , however hemorrhage , however about 20-30% of about 20-30% of papillary carcinomas papillary carcinomas also have a cystic also have a cystic component, indicating component, indicating that not all cystic that not all cystic thyroid nodules are thyroid nodules are benign.benign.
![Page 11: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/11.jpg)
Comet tail signComet tail sign
One highly specific One highly specific sign of a benignity sign of a benignity of a thyroid nodule of a thyroid nodule is the presence of is the presence of comet tail sign, comet tail sign, signifying a benign signifying a benign colloid nodule. colloid nodule. This sign is never This sign is never encountered in a encountered in a malignant lesionmalignant lesion
![Page 12: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/12.jpg)
EchogenecityEchogenecity
Hyperechoic nodule Hyperechoic nodule malignant in malignant in 4%4%
Isoechoic nodule Isoechoic nodule malignant in malignant in 26%26%
Hypoechoic nodule Hypoechoic nodule malignant in malignant in 63%63%
![Page 13: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/13.jpg)
![Page 14: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/14.jpg)
Margins Margins Peripheral halo of Peripheral halo of
decreased decreased echogenecity is seen echogenecity is seen around the nodule.around the nodule.
a complete halo is 12 a complete halo is 12 times more likely to times more likely to indicate benign lesionindicate benign lesion
An incomplete halo is An incomplete halo is 4 times more likely 4 times more likely benign than benign than malignantmalignant
![Page 15: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/15.jpg)
Calcification Calcification
Peripheral rim calcification and Peripheral rim calcification and large areas of coarse shadowing large areas of coarse shadowing calcifications are more frequently calcifications are more frequently seen in benign nodules’seen in benign nodules’
Fine punctate calcifications due to Fine punctate calcifications due to calcified psammoma bodies are more calcified psammoma bodies are more frequently seen in malignant nodulesfrequently seen in malignant nodules
![Page 16: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/16.jpg)
![Page 17: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/17.jpg)
![Page 18: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/18.jpg)
![Page 19: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/19.jpg)
Color flow imagingColor flow imaging There are three general patterns of vascular There are three general patterns of vascular
distribution of the thyroid nodule:distribution of the thyroid nodule: Type 1Type 1 : complete absence of flow signal : complete absence of flow signal
within the nodule.within the nodule. Type 2Type 2 : exclusive perinodular arterial flow : exclusive perinodular arterial flow
signalsignal““type 1 and 2” are more common with benign type 1 and 2” are more common with benign
nodulesnodules Type 3Type 3 : intranodular flow with or without : intranodular flow with or without
significant perinodular flow and this type is significant perinodular flow and this type is generally associated with malignant nodules.generally associated with malignant nodules.
![Page 20: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/20.jpg)
![Page 21: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/21.jpg)
![Page 22: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/22.jpg)
Although none of the Although none of the ultrasound features above ultrasound features above
is is BY ITSELFBY ITSELF pathognomonic for pathognomonic for
malignancy, BUT when it malignancy, BUT when it used used IN COMBINATIONIN COMBINATION they they
are very useful in are very useful in differentiating malignant differentiating malignant
from a benign nodulefrom a benign nodule
![Page 23: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/23.jpg)
What are the features of a What are the features of a benignbenign thyroid nodulethyroid nodule??
1- completely or nearly completely cystic, 1- completely or nearly completely cystic, especially with echogenic foci with especially with echogenic foci with comet tail artifactcomet tail artifact
2- echogenic or isoechoic to normal 2- echogenic or isoechoic to normal tissuetissue
3- a complete halo3- a complete halo
4- well described margin4- well described margin
5- rim or large coarse calcifications5- rim or large coarse calcifications
6- hypovasculrity6- hypovasculrity
![Page 24: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/24.jpg)
![Page 25: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/25.jpg)
What are the features ofWhat are the features of malignantmalignant thyroid nodule?thyroid nodule?
1- microcalcifications1- microcalcifications
2- irregular margin2- irregular margin
3- marked hypoechogenecity3- marked hypoechogenecity
4- hypervascularity4- hypervascularity
![Page 26: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/26.jpg)
![Page 27: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/27.jpg)
Examination of adjacent Examination of adjacent structuresstructures
(1)- (1)- CCA and CCA and internal jugular internal jugular veinvein : the presence : the presence of thrombus within of thrombus within CCA or IJV in CCA or IJV in association with a association with a thyroid nodule is a thyroid nodule is a clue to the clue to the malignant nature malignant nature of the noduleof the nodule
![Page 28: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/28.jpg)
(2) – (2) – spread to adjacent spread to adjacent structuresstructures; extrathyroid spread ; extrathyroid spread including involvement of esophagus, including involvement of esophagus, trachea, strap muscles, recurrent trachea, strap muscles, recurrent laryngeal nerve is another clue to laryngeal nerve is another clue to the malignant nature of the nodulethe malignant nature of the nodule
![Page 29: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/29.jpg)
![Page 30: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/30.jpg)
(3)- (3)- cervical lymphadenopathycervical lymphadenopathy The LNs commonly involved are the The LNs commonly involved are the
pretracheal , paratracheal and nodes pretracheal , paratracheal and nodes along internal jugular vein.along internal jugular vein.
![Page 31: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/31.jpg)
![Page 32: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/32.jpg)
MULTINODULAR THYROIDMULTINODULAR THYROID
ultrasound features:ultrasound features: Solid nodules, frequently isoechoicSolid nodules, frequently isoechoic well defined marginswell defined margins Cystic component in 60 %Cystic component in 60 % Heterogeneous internal echopattern Heterogeneous internal echopattern
with multiple septa , solid and cystic with multiple septa , solid and cystic portions.portions.
On color flow imaging the nodules On color flow imaging the nodules either show type 1 or type 2 patterneither show type 1 or type 2 pattern
![Page 33: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/33.jpg)
![Page 34: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/34.jpg)
![Page 35: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/35.jpg)
![Page 36: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/36.jpg)
It is generally believed that malignancy It is generally believed that malignancy is common in a solitary nodule and that is common in a solitary nodule and that multinodularity is usually associated multinodularity is usually associated with benign disease, with benign disease, HOWEVERHOWEVER 10 – 10 – 20 % of papillary carcinoma may be 20 % of papillary carcinoma may be multicentricmulticentric
![Page 37: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/37.jpg)
![Page 38: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/38.jpg)
![Page 39: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/39.jpg)
DIFFUSE THYROID DIFFUSE THYROID DISEASESDISEASES
• Grave's diseaseGrave's disease• Hashimoto thyroiditisHashimoto thyroiditis• De Quervain’s diseaseDe Quervain’s disease
![Page 40: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/40.jpg)
![Page 41: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/41.jpg)
GRAVE’S DISEASEGRAVE’S DISEASE
Diffuse enlarged glandDiffuse enlarged gland Color Doppler study is pathognomonic Color Doppler study is pathognomonic
for the disease , revealing for the disease , revealing hypervascularity which is called hypervascularity which is called “thyroid inferno”.“thyroid inferno”.
the peak systolic velocity is more than the peak systolic velocity is more than 100 cm/sec “normal up to 25 cm / sec”100 cm/sec “normal up to 25 cm / sec”
![Page 42: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/42.jpg)
![Page 43: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/43.jpg)
..
![Page 44: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/44.jpg)
![Page 45: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/45.jpg)
HASHIMOTO HASHIMOTO THYROIDITISTHYROIDITIS
Three stages:Three stages: Acute: enlarged in size and increased Acute: enlarged in size and increased
vascularity.vascularity. Chronic: enlarged gland with multiple Chronic: enlarged gland with multiple
linear bright echoes throughout the linear bright echoes throughout the hypoechoic parenchyma as well as hypoechoic parenchyma as well as multiple small hypoechoic nodules.multiple small hypoechoic nodules.
Atrophic; end stage : small atrophic gland. Atrophic; end stage : small atrophic gland. avascular with heterogenous echoes.avascular with heterogenous echoes.
![Page 46: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/46.jpg)
..
![Page 47: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/47.jpg)
![Page 48: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/48.jpg)
DE QUARVAN’S DE QUARVAN’S THYROIDITISTHYROIDITIS
The inflammation does not involve The inflammation does not involve the entire gland but infiltrates the the entire gland but infiltrates the gland in a non homogenous pattern.gland in a non homogenous pattern.
The sonographic correlate is a The sonographic correlate is a disordered pattern of hypoechoic disordered pattern of hypoechoic and hypervascular areasand hypervascular areas
![Page 49: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/49.jpg)
![Page 50: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/50.jpg)
Evaluation of nodules Evaluation of nodules incidentally detected by incidentally detected by
U/SU/S
Nodules under 1.5 cm are Nodules under 1.5 cm are followed up by u/sfollowed up by u/s
Nodules over 1.5 cm are Nodules over 1.5 cm are further evaluated by FNAfurther evaluated by FNA
![Page 51: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/51.jpg)
![Page 52: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/52.jpg)
ILLUSTRATED ILLUSTRATED CASESCASES
![Page 53: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/53.jpg)
![Page 54: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/54.jpg)
![Page 55: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/55.jpg)
![Page 56: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/56.jpg)
![Page 57: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/57.jpg)
![Page 58: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/58.jpg)
![Page 59: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/59.jpg)
![Page 60: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/60.jpg)
![Page 61: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/61.jpg)
![Page 62: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/62.jpg)
![Page 63: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/63.jpg)
![Page 64: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/64.jpg)
![Page 65: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/65.jpg)
![Page 66: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/66.jpg)
![Page 67: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/67.jpg)
![Page 68: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/68.jpg)
![Page 69: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/69.jpg)
![Page 70: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/70.jpg)
![Page 71: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/71.jpg)
![Page 72: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/72.jpg)
![Page 73: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/73.jpg)
![Page 74: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/74.jpg)
![Page 75: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/75.jpg)
![Page 76: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/76.jpg)
![Page 77: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/77.jpg)
![Page 78: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/78.jpg)
![Page 79: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/79.jpg)
![Page 80: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/80.jpg)
![Page 81: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/81.jpg)
![Page 82: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/82.jpg)
![Page 83: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/83.jpg)
![Page 84: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/84.jpg)
![Page 85: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/85.jpg)
![Page 86: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/86.jpg)
![Page 87: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/87.jpg)
![Page 88: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/88.jpg)
![Page 89: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/89.jpg)
![Page 90: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/90.jpg)
![Page 91: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/91.jpg)
![Page 92: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/92.jpg)
![Page 93: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/93.jpg)
![Page 94: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/94.jpg)
![Page 95: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/95.jpg)
![Page 96: Thyroid us](https://reader033.vdocument.in/reader033/viewer/2022061603/55654da6d8b42a9b4c8b4f29/html5/thumbnails/96.jpg)